Harpoon Therapeutics, Inc. EBITDA Margin 2019-2023 | HARP
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Harpoon Therapeutics, Inc. (HARP) over the last 10 years. The current EBITDA margin for Harpoon Therapeutics, Inc. as of September 30, 2023 is .
EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2023-09-30 |
$0.04B |
$-0.04B |
-100.00% |
2023-06-30 |
$0.05B |
$-0.03B |
-70.21% |
2023-03-31 |
$0.04B |
$-0.06B |
-160.00% |
2022-12-31 |
$0.03B |
$-0.07B |
-203.13% |
2022-09-30 |
$0.03B |
$-0.07B |
-209.38% |
2022-06-30 |
$0.02B |
$-0.07B |
-322.73% |
2022-03-31 |
$0.02B |
$-0.07B |
-350.00% |
2021-12-31 |
$0.02B |
$-0.11B |
-486.96% |
2021-09-30 |
$0.03B |
$-0.10B |
-396.15% |
2021-06-30 |
$0.03B |
$-0.10B |
-388.46% |
2021-03-31 |
$0.02B |
$-0.10B |
-426.09% |
2020-12-31 |
$0.02B |
$-0.05B |
-294.12% |
2020-09-30 |
$0.01B |
$-0.05B |
-441.67% |
2020-06-30 |
$0.01B |
$-0.06B |
-633.33% |
2020-03-31 |
$0.01B |
$-0.06B |
-814.29% |
2019-12-31 |
$0.01B |
$-0.06B |
-1160.00% |
2019-09-30 |
$0.00B |
$-0.05B |
-1275.00% |
2019-06-30 |
$0.00B |
$-0.04B |
-1000.00% |